Carbon Tetrachloride

Carbon Tetrachloride

SCHEMBL7950801

CCN(CC)CC.ClC(Cl)(Cl)Cl

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
CYP2E1 P05181 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloromethane SCHEMBL6905936 0.91
Chloromethane SCHEMBL375766 0.83 CYP2C9 (0.35) ALDH1A1
SCHEMBL1736341 0.82 ALDH1A1 (0.40) ALDH1A1TSHR
SCHEMBL30 0.82
SCHEMBL124190 0.82
Hypochlorous Acid SCHEMBL1019174 0.78
SCHEMBL7460196 0.78
Chlorolithium SCHEMBL9474737 0.78
SCHEMBL7628923 0.78
SCHEMBL9694495 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114196002-B Preparation method of transparent flame-retardant novel polycarbonate, polycarbonate and application thereof 万华化学(宁波)有限公司 2023-08-11 CN disclosed
CN-114411180-B Method for constructing sulfur (selenium) substituted phosphate compound by electrochemical hydrogen-releasing oxidation coupling 江西师范大学 2023-03-21 CN disclosed
CN-114525529-B Method for constructing sulfur (selenium) substituted thioester phosphate compound by electrochemical hydrogen-releasing oxidation coupling 江西师范大学 2023-03-10 CN disclosed
CN-114525529-A Method for constructing sulfur (selenium) substituted thioester phosphate compound by electrochemical hydrogen-releasing oxidation coupling 江西师范大学 2022-05-24 CN disclosed
CN-114411180-A Method for constructing sulfur (selenium) substituted phosphate compound by electrochemical hydrogen-releasing oxidation coupling 江西师范大学 2022-04-29 CN disclosed
CN-114196002-A Preparation method of transparent flame-retardant novel polycarbonate, polycarbonate and application thereof 万华化学(宁波)有限公司 2022-03-18 CN disclosed
CN-106076132-B A kind of graphene oxide modified polyamide composite nanometer filtering film and preparation method thereof 天津工业大学 2019-03-26 CN disclosed
CN-108021008-A Cleaning balde, handle box and electrophotographic image-forming apparatus 佳能株式会社 2018-05-11 CN disclosed
US-9593139-B2 Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-03-14 US disclosed
CN-106076132-A A kind of graphene oxide modified polyamide composite nanometer filtering film and preparation method thereof 天津工业大学 2016-11-09 CN disclosed
US-20140343139-A1 COMPOSITIONS, METHODS, AND KITS COMPRISING PLATINUM COMPOUNDS ASSOCIATED WITH A LIGAND COMPRISING A TARGETING MOIETY MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-11-20 US disclosed
WO-2014165782-A2 COMPOSITIONS, METHODS, AND KITS COMPRISING PLATINUM COMPOUNDS ASSOCIATED WITH A LIGAND COMPRISING A TARGETING MOIETY MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-10-09 WO disclosed
CN-103435688-A Novel method for preparing compound of natural glycosyl-1-phosphoryl dipeptide and phosphoramide UNIV JIANGXI NORMAL SCI & TECH 2013-12-11 CN disclosed
US-6265558-B1 COMPOUND OF LINKED NUCLEOSIDES HAVING THIOL GROUP ATTATCHED AT 5-PYRIMIDINE OR 2-, 6-, OR 8-PURINE POSITIONS; ATTACHMENT REPORTER MOLECULES, REPORTER ENZYMES, STEROIDS, LIPOPHILIC MOLECULES, PEPTIDES, PROTEINS AND OTHER GROUPS ISIS PHARMACEUTICALS, INC. 2001-07-24 US disclosed
EP-0716604-A4 THIOL-DERIVATIZED NUCLEOSIDES AND OLIGONUCLEOSIDES ISIS PHARMACEUTICALS INC (US) 2000-12-27 EP disclosed
US-6114513-A MEDICAL DIAGNOSIS; TRANSFER ACROSS CELL MEMBRANES ISIS PHARMACEUTICALS, INC. (US) 2000-09-05 US disclosed
US-5852182-A Thiol-derivatized oligonucleosides ISIS PHARMACEUTICALS INC. (US) 1998-12-22 US disclosed
US-5578718-A Thiol-derivatized nucleosides ISIS PHARMACEUTICALS, INC. (US) 1996-11-26 US disclosed
EP-0716604-A1 THIOL-DERIVATIZED NUCLEOSIDES AND OLIGONUCLEOSIDES ISIS PHARMACEUTICALS, INC. (US) 1996-06-19 EP disclosed
WO-1995006474-A1 THIOL-DERIVATIZED NUCLEOSIDES AND OLIGONUCLEOSIDES ISIS PHARMACEUTICALS, INC. (US) 1995-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343139-A1 COMPOSITIONS, METHODS, AND KITS COMPRISING PLATINUM COMPOUNDS ASSOCIATED WITH A LIGAND COMPRISING A TARGETING MOIETY DTYMK, PBK, PAICS ALDH1A1 2099/4885LMNA 2217/4885CYP2E1 4265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.